Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02937675
Title A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Effector Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Samuel Oschin comprehensive Cancer Institute at Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
Florida Cancer Specialist Sarasota Florida 34232 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
University of Rochester Rochester New York 14642 United States Details
Gabrail Cancer Center Research Canton Ohio 44718 United States Details
Baylor Scott & White Research Institute Dallas Texas 75246 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
West Virginia University Morgantown West Virginia 26506 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field